Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (641-650 of 723) with videos related to

Pageof 73
Sort By:
Cancer Surveys|January 1, 1995
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomyF Labrie, L Cusan, J L Gomez, et al.
Journal of Steroid Biochemistry|January 1, 1980
Steroid hormone receptors and pharmacologyJ P Raynaud, M M Bouton, M Moguilewsky, et al.
Biology of Reproduction|May 1, 1981
Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonistsC Séguin, A Bélanger, L Cusan, et al.
Cancer Genomics & Proteomics|September 20, 2007
Microarray analysis of survival pathways in human PC-3 prostate cancer cellsR Tenta, H Katopodis, A Chatziioannou, et al.
Journal of Steroid Biochemistry|January 1, 1987
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patientsF Labrie, A Dupont, M Giguere, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinomaA Dupont, F Labrie, M Giguere, et al.
Cancer Detection and Prevention|January 1, 1992
Androgens and breast cancerF Labrie, J Simard, Y de Launoit, et al.
L'Union Medicale Du Canada|January 1, 1989
[Total androgen blockade: an argument in favor]F Labrie, Y Lacourcière, A Bélanger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerJ Laverdière, J L Gomez, L Cusan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1982
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonistsG Tolis, D Ackman, A Stellos, et al.
Pageof 73

Showing results (641-650 of 723) with videos related to

Sort By:
Pageof 73
Cancer Surveys|January 1, 1995
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomyF Labrie, L Cusan, J L Gomez, et al.
Journal of Steroid Biochemistry|January 1, 1980
Steroid hormone receptors and pharmacologyJ P Raynaud, M M Bouton, M Moguilewsky, et al.
Biology of Reproduction|May 1, 1981
Relative importance of the adenohypophyseal and gonadal sites in inhibitory action of LHRH agonistsC Séguin, A Bélanger, L Cusan, et al.
Cancer Genomics & Proteomics|September 20, 2007
Microarray analysis of survival pathways in human PC-3 prostate cancer cellsR Tenta, H Katopodis, A Chatziioannou, et al.
Journal of Steroid Biochemistry|January 1, 1987
Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patientsF Labrie, A Dupont, M Giguere, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinomaA Dupont, F Labrie, M Giguere, et al.
Cancer Detection and Prevention|January 1, 1992
Androgens and breast cancerF Labrie, J Simard, Y de Launoit, et al.
L'Union Medicale Du Canada|January 1, 1989
[Total androgen blockade: an argument in favor]F Labrie, Y Lacourcière, A Bélanger, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancerJ Laverdière, J L Gomez, L Cusan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1982
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonistsG Tolis, D Ackman, A Stellos, et al.
Pageof 73